12 Health Care Stocks Moving In Thursday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Thursday's after-market session, several healthcare stocks experienced significant movements. Bio-Path Holdings, Biora Therapeutics, Mustang Bio, BIMI International Medical, Allarity Therapeutics, and China SXT Pharmaceuticals were among the gainers, with increases ranging from 6.06% to 9.0%. Conversely, Virpax Pharmaceuticals, iSpecimen, Portage Biotech, SINTX Technologies, Cyclo Therapeutics, and Benitec Biopharma saw declines between 6.16% and 18.2%.
April 18, 2024 | 8:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Biora Therapeutics shares increased by 8.4% to $0.65, with a market cap of $23.2 million.
Biora Therapeutics' stock price rise indicates a positive market reaction, possibly driven by recent company developments or favorable conditions in the healthcare market.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Bio-Path Holdings stock increased by 9.0% to $4.58, with a market cap of $3.4 million.
The significant after-market increase in Bio-Path Holdings' stock price suggests positive investor sentiment, potentially due to company-specific news or broader market trends affecting the healthcare sector.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Virpax Pharmaceuticals stock decreased by 18.2% to $3.2, with a market cap of $3.7 million.
The sharp decline in Virpax Pharmaceuticals' stock price could reflect negative investor sentiment or reactions to company-specific news, impacting short-term stock performance.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90